Breaking through convention to simplicity in type 2 diabetes care – Case study 2
This expert-led case study uses fixed-dose combination insulin/GLP-1 agonist therapy to reduce complications of type 2 diabetes mellitus
Learning objectives
You will learn:
- The benefits of using fixed-dose combination insulin/GLP-1 agonist therapy to reduce complications of type 2 diabetes mellitus (T2DM)
- An understanding of the mechanism of action of GLP-1 agonists and how to use these agents safely and effectively
- An understanding of the criteria that determine individualised HbA1c targets
- An approach to the management of comorbid dyslipidaemia and hypertension.
To access this module, please register or login: